Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Debt Ratio (2018 - 2023)

Historic Debt Ratio for Protagonist Therapeutics (PTGX) over the last 6 years, with Q2 2023 value amounting to 0.0.

  • Protagonist Therapeutics' Debt Ratio fell 8788.83% to 0.0 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.0, marking a year-over-year decrease of 8788.83%. This contributed to the annual value of 0.0 for FY2022, which is 8923.63% down from last year.
  • Per Protagonist Therapeutics' latest filing, its Debt Ratio stood at 0.0 for Q2 2023, which was down 8788.83% from 0.0 recorded in Q1 2023.
  • In the past 5 years, Protagonist Therapeutics' Debt Ratio registered a high of 0.03 during Q2 2021, and its lowest value of 0.0 during Q2 2023.
  • Its 5-year average for Debt Ratio is 0.01, with a median of 0.0 in 2019.
  • As far as peak fluctuations go, Protagonist Therapeutics' Debt Ratio soared by 53236.05% in 2021, and later crashed by 9908.61% in 2022.
  • Protagonist Therapeutics' Debt Ratio (Quarter) stood at 0.01 in 2019, then grew by 3.36% to 0.01 in 2020, then crashed by 69.29% to 0.0 in 2021, then crashed by 89.24% to 0.0 in 2022, then plummeted by 88.79% to 0.0 in 2023.
  • Its Debt Ratio stands at 0.0 for Q2 2023, versus 0.0 for Q1 2023 and 0.0 for Q4 2022.